Pilar Azevedo
Lisbon, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Determinants of early Elexacaftor-Tezacaftor-Ivacaftor use in adults with cystic fibrosis and preserved lung function: insights from a European multicenter survey.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: November 21, 2025
Personalized Medicine in Cystic Fibrosis: Characterization of Eight Rare CFTR Variants in Intestinal Organoids and Cellular Models.
Journal: Molecular diagnosis & therapy
Published: July 29, 2025
Impact of elexacaftor/tezacaftor/ivacaftor on the small airways in cystic fibrosis.
Journal: Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia
Published: December 12, 2024
Elexacaftor/tezacaftor/ivacaftor, a game-changer in cystic fibrosis: The Portuguese experience.
Journal: Pulmonary pharmacology & therapeutics
Published: July 09, 2024
The phenomenon of skin contraction in CO2 LASER surgical incisions using superpulse and continuous emission mode - preliminary study.
Journal: Lasers in medical science
Published: February 01, 2024
Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: November 06, 2023
Safety and efficacy of vanzacaftor-tezacaftor-deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials.
Journal: The Lancet. Respiratory medicine
Published: September 29, 2022
Elexacaftor/tezacaftor/ivacaftor-real-world clinical effectiveness and safety. A single-center Portuguese study.
Journal: Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia
Published: August 30, 2022
Mepolizumab in severe asthma exacerbation in a respiratory ICU-a successful off-label use.
Journal: Pulmonology
Published: June 27, 2022
CHEMOTHERAPY HAZARDS: ANTHRACYCLINE EXTRAVASATION INTO PLEURAL SPACE.
Journal: Portuguese journal of cardiac thoracic and vascular surgery
Published: April 11, 2022
The effect of premature termination codon mutations on CFTR mRNA abundance in human nasal epithelium and intestinal organoids: a basis for read-through therapies in cystic fibrosis.
Journal: Human mutation
Published: July 02, 2018
Cystic fibrosis - Comparison between patients in paediatric and adult age.
Journal: Revista portuguesa de pneumologia
Published: October 19, 2015
Last Updated: 09/26/2026